CUE
Cue Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CUE fundamentals
Cue Biopharma (CUE) released its earnings on Aug 12, 2025: revenue was 2.95M (YoY +10.90%), beat estimates; EPS was -0.09 (YoY +55.00%), beat estimates.
Revenue / YoY
2.95M
+10.90%
EPS / YoY
-0.09
+55.00%
Report date
Aug 12, 2025
Earnings Call
4:30 PM on Aug 18, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
CUE has released its 2025 Q3 earnings report, with revenue of 2.15M, reflecting a YoY change of -35.58%, and net profit of -7.45M, showing a YoY change of 14.00%. The Sankey diagram below clearly presents CUE's revenue sources and cost distribution.
Key Indicators
Cue Biopharma (CUE) key financial stats and ratios, covering profitability, financial health, and leverage.
Cue Biopharma (CUE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Cue Biopharma (CUE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cue Biopharma (CUE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Cue Biopharma (CUE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Cue Biopharma (CUE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Cue Biopharma's earnings call?What is Cue Biopharma's latest dividend and current dividend yield?What were the key takeaways from Cue Biopharma’s earnings call?What is the market's earnings forecast for Cue Biopharma next quarter?What guidance did Cue Biopharma's management provide for the next earnings period?What does Cue Biopharma do and what are its main business segments?What factors drove the changes in Cue Biopharma's revenue and profit?Did Cue Biopharma beat or miss consensus estimates last quarter?
